As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...